Who Should Attend:

All physicians, nurse practitioners, and physician assistants who desire to improve their patients' overall health.

Agenda:

November 30, 2007

6:30 am - 7:30 am Registration and Complimentary Continental Breakfast

7:30 am - 12:10 pm Morning Sessions

12:10 pm - 12:40 pm Complimentary Lunch

12:40 pm - 5:00 pm Afternoon Sessions


December 1, 2007

6:30 am - 7:30 am Registration and Complimentary Continental Breakfast

7:30 am - 12:10 pm Morning Sessions

12:10 pm - 12:40 pm Complimentary Lunch

12:40 pm - 3:35 pm Afternoon Sessions


Topics

Prevent the Event: Long Term Management of the Stroke Patient

Dyslipidemia: From Evidence to Implementation: Getting Patients to Goal

Cardiovascular Risk and the Endocannabinoid System

Improving the Efficacy and Safety of Inhaled Corticosteroids: Therapy in the 21st Century

Sleep-Wake Disturbances: What You Need to Know to Recognize, Diagnose, and Manage them in Your Practice

Think Pink: Bacterial Conjunctivitis and the Red Eye

Rheumatoid Arthritis: Primary Care Initiative for Improved Diagnosis and Outcomes

Chronic Constipation and IBS-C: A Primary Care Guide to Treatment Today

Best Practices for the Type 2 Diabetic Patient and Thiazolidinediones

Prevention, Detection, and Management of Venous Thromboembolism in Special Patient Populations

All Fractures are Not Created Equal: Appropriate Identification and Treatment of Nonvertebral Fractures

Venue Information:


Meeting Room: Ballroom A, D & E

Self Parking $9.00 daily rate, $17.00 overnight rate

Hotel Accommodations
The Westin Providence
One West Exchange Street
Providence, RI 02903
401-598-8000

A limited number of rooms have been reserved at the Westin Providence at a rate of $169 per night. For reservations, call 800-937-8461 and mention the Primary Care Network room block. Reservations must be made by October 30, 2007 in order to receive the discounted rate.
*The Westin Providence is connected to the RI Convention Center

Presenting Faculty:

Peter Weissman, MD
Adjunct Director, Continuing Medical Education
Joslin Diabetes Center - Boston, MA
Assistant Clinical Professor of Medicine and Endocrinology
University of Miami
Miami, FL


Seth Braunstein, MD, PhD
Associate Professor of Medicine
University of Pennsylvania School of Medicine
Philadelphia, PA




Suzanne Rose, MD


Jay Goldstein, MD


Christopher Drake, PhD
Assistant Professor of Psychiatry and Behavioral Neurosciences, Wayne State College of Medicine
Bioscientific Staff, Henry Ford Hospital Sleep Center
Detroit, MI

Mary O'Malley, MD, PhD
Fellowship Director in Sleep Medicine, Norwalk Hospital Sleep Disorders Center
Clinical Instructor in Psychiatry, New York University Medical Center
Norwalk, CT

Bhuvaneswari K. Dandapani, MD
Vascular Neurologist
Director, Stroke Program
Holmes Regional Medical Center
Melbourne, FL


Lawrence E. Mieczkowski, MD
Clinical Associate Professor of Medicine
Wright State University School of Medicine
Dayton, OH

Timothy J. Craig, DO
Professor of Medicine and Pediatrics
Pennsylvania State University College of Medicine
Chief of Allergy and Immunology
Director of Clinical Respiratory and Allergy Research
Milton S. Hershey Medical Center
Hershey, PA

Eric J. Schenkel, MD
Director, Valley Allergy & Asthma Treatment Center
Easton, PA


Emma Meagher, MD
Associate Professor
University of Pennsylvania, School of Medicine
Philadelphia, PA

Robert Schainfeld, DO
Associate Director, Vascular Medicine
Massachusetts General Hospital
Boston, MA

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainesville, FL

Yvonne Sherrer, MD


Ernesto Canalis, MD
St. Francis Hospital and Medical Center
Department of Research
Hartford, CT

John Bilezikian, MD


Tommy Korn, MD, FACS
Attending Ophthalmologist, Cornea-External Disease Service
Sharp Memorial Hospital - San Diego, CA
Assistant Clinical Professor of Ophthalmology
University of California, San Diego - School of Medicine

Arthur P. Wheeler, MD, FCCP
Associate Professor of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine
Director, Medical Intensive Care
Director, Vanderbilt Clinical Trials Coordinating Center
Vanderbilt University
Nashville, TN

Robert Rakel, MD
Professor, Family and Community Medicine
Baylor College of Medicine
Houston, TX

Samer Ellahham, MD
Clinical Professor, George Washington University Hospital
Washington, DC

Accreditation:

ACCME
Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this educational activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP
This activity has been reviewed and is acceptable for up to 14.75 Prescribed credits by the American Academy of Family Physicians.

AANP
This program has been approved for 14.6 contact hours of continuing education (which includes 5.6 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0708363.

AAPA
AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by ACCME.

Overview

Emerging Science - Expanding Knowledge

Helping patients. In today's growing practice, you have more and more demands on your time - and less time with each patient. It can be difficult to keep up with the latest research and new science emerging on an almost daily basis. How do you translate the knowledge gained into improved patient outcomes?

Best Practices in Primary Care turns the latest emerging science into better patient care. The education will engage you, the practicing clinician, by providing the latest research in a case-based, patient centered program. The goal of Primary Care Network and Best Practices in Primary Care is to provide the tools that you can use immediately in your daily practice, expanding your knowledge and ultimately improving patients' outcomes.

Offering the participating clinician up to 14.75 hours of CME in a variety of therapeutic areas, Best Practices in Primary Care, brings together case-based education presented by nationally recognized faculty. Over the intensive two day educational program, you will have the opportunity to participate in an impactful learning experience through 11 different symposia, dialogue with key opinion leaders, and interact with your colleagues.

Learning Objectives

• Recognize that TZDs are a beneficial option for treating many patients with type 2 diabetes, while monitoring the risks associated with the drug

• Implement pharmacologic interventions, utilizing TZDs, as an adjunct to diet and exercise for patients with type 2 diabetes

• Identify the signs and symptoms that differentiate chronic constipation from IBS-C and review the causes of these conditions in different patient populations

• Review the alarm signs and symptoms which will affect the management of chronic constipation and IBS-C and identify the therapies that can be used to treat these disorders

• Improve recognition of sleep-wake disturbances and identify comorbid sleep, psychiatric, neurologic, or medical etiology of these disturbances

• Develop an appropriate management plan for sleep-related problems that may incorporate nonpharmacologic or pharmacologic strategies, as well as referral to local sleep specialists

• Name 3 modifiable and 3 non-modifiable risk factors for ischemic stroke

• List 5 current treatment recommendations for survivors of ischemic stroke or TIA to prevent future events

• Review the latest guidelines to aid in early diagnosis and selecting the appropriate therapy and management based on individualization of patient needs

• Discuss the role of inhaled corticosteroids, novel agents, and asthma management practices in the treatment of patients with mild to moderate persistant asthma

• Evaluate patients for their risk of coronary heart disease by using the Framingham risk assessment scales and set new LDL-cholesterol treatment goals established by the NCEP ATP-III guidelines

• Understand how to use existing pharmacologic agents available when necessary, in order to attain NCEP ATP-III lipid goals and improve patient outcomes

• Examine appropriate RA patient management through a collaborative team approach

• Identify and address barriers to diagnosis and improved outcomes for RA in the primary care setting

• Evaluate therapeutic options for selection of optimal strategies to prevent nonvertebral fractures

• Identify specific risk factors and components of bone strength and understand their importance in assessing patients with osteoporosis

• Be aware of new diagnostic tests to distinguish bacterial from viral conjunctivitis, implement early intervention treatment, and understand bacterial conjunctivitis

• Understand the mean inhibitory concentrations and tissue penetration of available ophthalmic agents and discuss enhanced time at target tissue by delivery vehicles

• Outline the incidence of VTE in the primary care setting, the frequent patient characteristics and comorbidities that increase VTE risk and complicate medication management, and the potential impact of more widespread risk stratification and prophylaxis on morbidity and mortality

• Implement the AAFP/ACP guidelines for screening, diagnosis, and management of DVT and PE in clinical practice and initiate evidence-based prophylactic measures to improve primary care patient outcomes

• Understand how to manage and appropriately treat overweight and obese patients according to the NIH guidelines

• Understand the safety and efficacy of conventional (orlistat, sibutramine) and novel (rimonabant) pharmacotherapies for abdominal obesity

Grant Statement

This program is supported through educational grants from the following sponsors: Abbott; The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis U.S.); ALTANA Pharma US - A Nycomed Company; Amgen Inc.; Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; Centocor Inc.; Cephalon, Inc.; GlaxoSmithKline; Inspire Pharmaceutics, Inc.; Merck/Schering-Plough Pharmaceuticals; sanofi-aventis U.S.; Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc.; and Wyeth Pharmaceuticals Corporation.

Primary Care Network complies with the Americans with Disabilities Act. If you require special services to support your participation in this continuing education program, contact us directly at 877-594-1770.

Overnight accommodations and parking fees are the responsibility of the participant of this CME activity. Please contact the hotel hosting this program to book overnight accommodations.